• AIM: To describe long term follow-up in a family with GUCY2D dominant cone dystrophy.
INTRODUCTION
C one dystrophies (CD) and cone-rod dystrophies (CRD) are a group of genetic disorders, which demonstrate a large degree of heterogeneity and severity. The most frequent mode of inheritance is autosomal dominant, although autosomal recessive and X-linked recessive modes of inheritance have also been reported [1] . The main symptoms are decreased central visual acuity (VA), markedly decreased color vision, hemeralopia, nystagmus and loss of peripheral vision [2] . In pure cone dystrophies, only cone function is affected, while rod function remains intact. The photopic electroretinograms (ERG) demonstrates abnormalities but the scotopic ERG is grossly normal. Conversely, in cone-rod dystrophies, patients demonstrate features suggestive of rod dysfunction as well. In CRD, both photopic and scotopic ERGs will be abnormal [1] [2] [3] . It is rare to have a pure cone dystrophy because of the reciprocal relationship between the cone and rod system [3] . The usual natural history of CRD starts initially by forming some non-specific retinal pigment epithelial (RPE) granularity and mottling at the macular level. As the disease progresses, a typical bull's eye lesion develops, but not universally. Endstage disease with photoreceptor degeneration and RPE loss will result in geographic atrophy [3] . There is a wide range of genes implicated in the pathogenesis of CRD. The most common ones are SEMA4A, AIPL1, CRX, GUCA1A, GUCY2D, PITPNM3, PRPH2, PROM1, RIMS1 and UNC119 [4] . Both family members were found to have mutation in the retinal guanylyl cyclase 1 gene (also known as guanylate cyclase 2D/GUCY2D), which is known to be implicated in the autosomal dominant form of cone/cone-rod dystrophy. Retinal guanylyl cyclase 1 is an enzyme expressed within the retina responsible for the conversion of guanosine 5'-triphosphate to cyclic guanosine monophosphate (cGMP) [4] . [4] . Mutations in GUCY2D gene have been described in cone-rod dystrophy-6 and Leber congenital amaurosis [5] . In this manuscript, we describe the long-term clinical and multimodal imaging findings over the course of 13y in two family members diagnosed with GUCY2D cone dystrophy. To the best of our knowledge, this is the longest follow-up described so far in literature.
SUBJECTS AND METHODS
All procedures were compliant and consistent with the tenets of the Declaration of Helsinki. Informed consent was obtained from all individual participants included in this retrospective study. A retrospective review of the electronic records of two family members (father and son) was conducted at the Eye Unit of University Hospital Southampton National Healthcare System Foundation Trust, UK. Both patients were followedup annually at the Eye Unit for the last 13y and had a full past medical, ophthalmic and genetic history taken during the initial presentation. Annual follow-up visits were conducted including multimodal imaging. Optical coherence tomography (OCT) scans were obtained with the use of Triton/OCT-2000 (Topcon Ltd, Tokyo, Japan), whereas fundus autofluorescence (FAF) images were taken using Spectralis (Heidelberg Engineering, Heidelberg, Germany). Goldmann visual field (GVF) testing was utilised to monitor the progression of central field loss. Flash and pattern ERGs were recorded using corneal Dawson-Trick-Litzkow (DTL) thread electrodes. Flash ERGs were recorded after dilatation in compliance with International Society for Clinical Electrophysiology of Vision standards [6] . Occipital full-field checkerboard reversal visual evoked potentials (VEPs) were recorded to stimulus check sizes ranging from 10 to 120min of arc.
Both patients underwent genetic testing: the participants underwent whole exome sequencing in order to identify the genetic cause of their CD. DNA was isolated from blood, exome enrichment performed using the Agilent SureSelect Human All Exon V5 kit (© Agilent Technologies, Inc), and sequencing performed on the Illumina HiSeq 2000 platform (© Illumina Inc ® ). Data analysis was performed as previously described [7] . Genetics variants were filtered to identify variants present in both individuals within candidate genes identified through the Human Gene Mutation Database (namely ABCA4,
CACNA2D4, CNGA3, CNGB3, CRB1, CRX, GUCA1A, GUCY2D, KCNV2, MERTK, orf15, PDE6C, PDE6H, PITPNM3 & PRPH2).

RESUlTS
Genetic Testing Exome sequencing identified the heterozygous variant GUCY2D:c.2512C>T:p.Arg838Cys (rs61750172, also known as R838C) in both patients ( Figure 1 ). This mutation has been previously reported to cause cone-rod dystrophy 6 (CORD6; OMIM #601777) [8] . For abbreviation purposes, the father has been allocated the symbol P1 in generation II, whereas the son has been allocated the symbol P2 in generation III. There was also a history of eye problems in patient I1. There was insufficient data in past medical history to confirm a formal diagnosis of CD; hence the question mark symbol (Figure 1 ).
Clinical Findings
The cumulative clinical features for each patient are summarized in Table 1 . Both patients exhibited decline in VA combined with hemeralopia in adolescence but neither of them complained of nyctalopia. In addition, there were no significant media opacities to account for decline in VA in both of our patients. Figure 2 demonstrates the fluctuation of best-corrected visual acuity (BCVA) in both family members over the 13y follow-up at Southampton Eye Unit.
Multimodal Imaging
The macular OCT scans of P1 showed progressive loss of the ellipsoid layer at the level of the fovea with gradual thinning and atrophy of the adjacent retinal tissue and reverse shadowing due to cone and RPE cell loss . These changes have occurred in both eyes but the left eye appears to be more affected than the right. The macular OCT scan of the right eye of P2 demonstrated gradual macular thinning and atrophy, whereas the macular structure in the left eye remained relatively stable. Unlike the father's OCT scans, there was no disruption of the ellipsoid layer ( Figure 3C, 3D ). FAF images of the son showed features suggestive of bilateral foveolar hyper-AF. The hyper-AF involving the central foveolar area which can be seen in Figure 4C and 4D, are similar to the changes previously reported in type-2 idiopathic macular telangiectasia [9] . FAF findings also demonstrated RPE granular changes.
Electrophysiology The father's flash ERGs showed wellpreserved rod function (amplitude of responses smaller than average but within normal range) but significantly impaired cone function. Pattern ERGs as well occipital pattern VEPs were attenuated and degraded indicating reduced macular function. The son's cone responses were of borderline normal amplitude on initial presentation but became significantly degraded ten months later suggesting cone dysfunction ( Figure 5 ). Rod responses were normal. Pattern ERGs and occipital pattern VEPs were significantly degraded indicating reduced macular function. DISCUSSION So far, 223 mutations in the GUCY2D gene have been described. The Arg838Cys (R838C) mutation described in both of our patients has been previously reported by Kellsell et al [10] in 1998 in cone dystrophy 6. It is reported to cause a milder clinical phenotype compared to other mutations in the GUCY2D gene [11] . The mild phenotype of this particular mutation has been described by others in the past [12] [13] .
Other GUCY2D mutations on the same codon (R838S, R838H, R838P, R838G) can lead to a more aggressive clinical picture [14] [15] . Based on ERG recordings, two major types of cone-rod dystrophy were differentiated according to the phenotypic classification by Szlyk et al [16] . In type 1, cone amplitudes were reduced to a greater degree than rod amplitudes, while in type 2, cone and rod ERG amplitudes were reduced in equal proportion. According to the phenotypic classification by Szlyk et al [16] , both of our patients could be classified as phenotype 1a.
The father presented to the Ophthalmology Department with bilateral bull's eye maculopathy and mild temporal disc pallor. Bull's eye maculopathy can be caused by genetically inherited conditions or toxic retinopathies, hence it is not disease specific for cone/cone-rod dystrophy [3] . Disc pallor is also a non-specific finding but has been reported previously in a patient with cone dystrophy [17] , who had normal to near normal VA and color vision and abnormal peripheral cone function. However, in the father's case, the macula function was already compromised and the peripheral retina was normal. His son exhibited non-specific RPE granular changes but no other significant abnormalities. Bull's eye maculopathy was not observed in the son's case confirming that bull's eye maculopathy is not a universal sign [3] . This may be merely due to the chronicity of the disorder in his father. Moreover, the presence of a bull's eye maculopathy does not always correlate accurately with the extent of retinal dysfunction [18] . All the above observations confirm that the diagnosis of CD/CRD cannot rely exclusively on fundoscopy due to the non-specific clinical findings [19] . On spectral-domain optical coherence tomography (SD-OCT), the father exhibited progressive loss of the ellipsoid layer and gradual thinning and atrophy of the parafoveal retinal tissue and reverse shadowing due to cone and RPE cell loss. There was also obscurity at the level of the external limiting membrane (EML). This is consistent with the findings of others [19] [20] [21] [22] [23] . His son, however, had thinning but no loss of the ellipsoid layer. FAF imaging from the father's fundus was consistent with the OCT findings. Furthermore, the surrounding hyper-AF around the annular area of hypoautofluorescence suggests gradual deposition of lipofuscin material, a byproduct of the photoreceptor cell visual cycle and RPE metabolism. Lipofuscin accumulation can be toxic to the RPE and photoreceptor cells and this can lead to death of RPE and photoreceptors and that can cause further thinning and atrophy of the macula [24] . The FAF findings from the father's fundus are consistent with observations of another paper [25] .
The RPE granular changes observed in the son's fundus were also observed by FAF. Hence, FAF is useful as an adjuvant means of imaging when SD-OCT cannot detect subtle RPE or retinal abnormalities. FAF images showing a subtle bilateral hyper-AF signal mimicking changes that were previously described in Type 2 Macular Telangiectasia might be a reliable early indicator of the disease especially when ERGs are found to be border-line normal as in P2 in this case series [7] . Only one paper by Cho et al [26] has attempted to describe in depth and classify the different types of structural retinal abnormalities in patients with CD/CRD. This was a five year observational follow-up in 15 patients with cone dystrophy. Prior to this study, Hood et al [21] reported decreased intensity in the ellipsoid layer in 6 patients with cone dystrophy. Birch et al [27] reported that the thickness of the outer nuclear layer and the sum of thickness of the RPE and outer segment correlated well with visual field sensitivity [20, 24] . However, neither paper described the structural changes of the retina in patients with cone dystrophies. Cho et al [26] divided the morphological changes in the retinal structure in cone dystrophy patients into four different categories: 0, 1, 2 and 3. Category 0 exhibited no structural abnormalities, whereas category 1 showed foveal ellipsoid layer loss and obscurity of the border between the ellipsoid band and ELM. Category 2 showed foveal thinning and focal foveal ellipsoid layer disruption with an intact ELM. Finally, category 3 showed foveal thickening and perifoveal disruption of the ellipsoid layer. Based on this classification, the father demonstrated changes matching category 1. The son did have foveal thinning but no disruption of the ellipsoid layer, hence he could potentially be classified as category 0. In the Cho et al's [26] paper, it was observed that category 0 patients were younger than the other categories, although this observation was not proven to be statistically significant. Ageing is likely to be a contributing factor to disease progression with subsequent disruption of the photoreceptor outer segment/ellipsoid layer. Moreover, in the paper by Cho et al [26] , only one patient was found to meet the category 3 criteria. The authors formed the hypothesis that the thickening of the fovea could be attributed to the gradual deposition of tissue remnants of the unhealthy and gradually dying photoreceptors. This SD-OCT finding has been described previously in patients with peripherin/ RDS gene mutations [28] . However, in patients with CD due to GUCY2D mutations, category 1 abnormalities have been previously described (GUCY2D Arg838His). The difference to the case described by Kim et al [29] (GUCY2D Arg838His) is that our patients had the GUCY2D Arg838Cys mutation. Nevertheless, the morphological features on SD-OCT are similar. Electrophysiological testing is arguably the most diagnostic test, should CD/CRD be suspected. Fundus examination can show non-specific changes and the multimodal imaging findings in patients with cone dystrophy are quite heterogeneous and therefore fundoscopy, SD-OCT and FAF are not diagnostic. This is also supported by Cho et al [26] , who observed that category 0 patients had a significantly affected ERG, while no structural abnormalities were observed. In addition, it is obvious that electrophysiological responses do not correlate well with SD-OCT findings. Thus, ERG and VEP can confirm the macula/cone dysfunction much earlier than other imaging modalities and therefore they both are an irreplaceable adjuvant diagnostic tool for any Medical Retina Specialist in the diagnosis and management of patients diagnosed with CD/CRD. To the best of our knowledge, this is the longest duration of follow-up of patients with CD associated with mutations in GUCY2D. We describe the progression of the disease based on VA and multimodal imaging. Electrophysiological testing is most useful for the clinical diagnosis of CD/CRD, while SD-OCT and FAF imaging are both useful for monitoring disease progression and genotype-phenotype correlations can be identified by molecular analysis.
